Viral inactivation is a viral removal process in which the infections may remain in the final product but a non-infective form. Viral inactivation is utilized majorly in the blood plasma industry. Viral inactivation is an essential part of the viral clearance process, which is compulsory for any drug development process. Several regulatory authorities, such as FDA, have confirmed the need for viral inactivation in multiple applications such as stem cell products, cellular & gene therapy, vaccines, therapeutics, tissue & tissue products, and blood & blood products.
MARKET SCOPE
The "Global Viral Inactivation Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the viral inactivation market with detailed market segmentation by method, product, application, end user, and geography. The report provides key statistics on the market status of the leading viral inactivation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on method, the global viral inactivation market is segmented into solvent detergent method, pasteurization, other methods.
- Based on product, the global viral inactivation market is segmented into kits & reagents, services, viral inactivation systems & accessories
- Based on application, the global viral inactivation market is segmented into vaccines & therapeutics, blood & blood products, cellular & gene therapy products, tissues & tissue products, stem cell products
- Based on end user, the market is bifurcated into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, other end users.
MARKET DYNAMICS
Drivers:
- Fast growth in pharmaceutical & biotechnology industries
- Rising number of new drug launches
- Growing government support for pharmaceutical & biotechnology industries
- Strong R&D investments in the life sciences industry
Restraints:
- Consolidation to act as a major barrier for new entrants
- HIgh costs associated with the manufacture of biosimilar products
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Viral inactivation market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Viral inactivation market in these regions.
?
IMPACT OF COVID-19 ON VIRAL INACTIVATION MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Viral inactivation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Viral inactivation market are anticipated to lucrative growth opportunities in the future with the rising demand for Viral inactivation in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Viral inactivation market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Merck KGaA
- Danaher
- Sartorius AG
- Charles River
- SGS SA
- PARKER HANNIFIN CORP
- Clean Cells
- Rad Source Technologies
- Texcell
- WuXi AppTec